Figure 1.
Phase 2a study schema of CD24Fc for GVHD prevention. Two ascending single-dose cohorts and a multidose cohort. BM, bone marrow; PBSC, peripheral blood stem cell.

Phase 2a study schema of CD24Fc for GVHD prevention. Two ascending single-dose cohorts and a multidose cohort. BM, bone marrow; PBSC, peripheral blood stem cell.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal